News
Search EMA's news announcements
We are currently carrying out work to improve the usability of our search function. This may cause search results to be incomplete. We anticipate this issue will be resolved in the coming hours. To fetch data from this website via automated systems, please use our JSON data files.
Enhanced EU collaboration to allow faster and wider access to innovative health technologies
EMA and HMA update principles for identification and disclosure of commercially confidential information and personal data
EMA's Executive Director shares her end-of-year message and takes stock of EMA's work in 2024
The European Medicines Agency's (EMA) office is closed from 18:00 on 19 December 2024 to 08:30 on 6 January 2025
Report outlines recommendations and next steps
Work programme and budget for 2025 among other topics
Emcitate can be used in patients of all ages
Benefit of medicine used in Crohn’s disease no longer demonstrated
Oral medicine to treat two different conditions, rare von Hippel-Lindau disease and advanced clear cell renal cell carcinoma
Seventeen new medicines recommended for approval; another eight medicines recommended for extension of their therapeutic indications